CD4+ T-Cell Counts May Predict Rituximab Response in RA (CME/CE)

(MedPage Today) -- Could assist in re-treatment timing
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Rituxan